Venus Concept Inc. (VERO)
| Market Cap | 99.17M |
| Revenue (ttm) | 98.82M |
| Net Income (ttm) | -33.37M |
| Shares Out | 63.98M |
| EPS (ttm) | -0.66 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 244,891 |
| Open | 1.49 |
| Previous Close | 1.56 |
| Day's Range | 1.47 - 1.60 |
| 52-Week Range | 1.17 - 3.44 |
| Beta | 1.30 |
| Analysts | Buy |
| Price Target | 5.31 (+242.6%) |
| Earnings Date | n/a |
About VERO
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Velocity and Venus Epileve, a diode laser device for hair removal, permanent hair reduction, and trea...
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for Venus Concept stock is "Buy." The 12-month stock price forecast is 5.31, which is an increase of 242.58% from the latest price.
News
Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX for Non-Invasive Lipolysis of the Abdomen and Flanks, C...
TORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has received 510(k)...
Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2021
TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenu...
Penny Stocks To Buy Now According To Insiders In December 2021
Insiders are buying these penny stocks during "tax loss season" The post Penny Stocks To Buy Now According To Insiders In December 2021 appeared first on Penny Stocks to Buy, Picks, News and Information...
Venus Concept Stock Down As Q3 Earnings Trail Street Expectations
Venus Concept Inc's (NASDAQ: VERO) Q3 sales increased 19% Y/Y to $24.6 million, missing the consensus of $26.43 million. On a sequential basis, the sales declined around 5%.
Venus Concept Announces Third Quarter and First Nine Months of 2021 Financial Results; Updates Fiscal Year 2021 Reven...
TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three a...
Venus Concept (VERO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Venus Concept's Pain Management Device Scores FDA Nod
The FDA has given 510(k) clearance to Venus Concept Inc's (NASDAQ: VERO) Venus Freedom device for pain management. Venus Freedom is a noninvasive, non-ablative device with three applicators to deliver n...
Venus Concept Receives FDA 510(k) Clearance for the Venus Freedom™
TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received 510(k)...
Venus Concept Appoints Ross J. Portaro as President of Global Sales
TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the appointment of Ross J. ...
Venus Concept to Release Third Quarter of Fiscal Year 2021 Financial Results on November 12, 2021
TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year...
Venus Concept Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will parti...
Venus Concept Stock Trades Higher After Lifting FY21 Sales Outlook
Venus Concept Inc's (NASDAQ: VERO) Q2 sales increased 52% Y/Y to $25.8 million, beating the consensus of $24.26 million. The increase by product category was driven by a 71% increase in lease revenue, a...
Venus Concept (VERO) Reports Q2 Loss, Tops Revenue Estimates
Venus Concept (VERO) delivered earnings and revenue surprises of 71.43% and 6.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Venus Concept Q2 Earnings
Shares of Venus Concept (NASDAQ:VERO) rose 15.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 102.56% year over year to $0.01, which beat the...
Venus Concept Announces Second Quarter 2021 Financial Results; Increases Fiscal Year 2021 Revenue Guidance
TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three a...
Will Venus Concept (VERO) Report Negative Earnings Next Week? What You Should Know
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Venus Concept Announces Health Canada Authorization and CE Mark for Venus Fiore® Feminine Health System
TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medi...
Venus Concept Inc. to Participate in the Ladenburg Thalmann Healthcare Conference on July 13th
TORONTO, July 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will partic...
Venus Concept to Release Second Quarter of Fiscal Year 2021 Financial Results on August 13, 2021
TORONTO, July 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that second quarter of fiscal yea...
Venus Concept Announces First Quarter of 2021 Financial Results; Increases Fiscal Year 2021 Revenue Guidance
TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three mo...
Moving Average Crossover Alert: Venus Concept (VERO)
Venus Concept (VERO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Venus Concept to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal yea...
Venus Concept (VERO) Reports Q4 Loss, Tops Revenue Estimates
Venus Concept (VERO) delivered earnings and revenue surprises of -37.50% and 0.51%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept: Q4 Earnings Insights
Shares of Venus Concept (NASDAQ:VERO) increased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 74.77% over the past year to ($0.27), which misse...
Venus Concept Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Reaffirms Fiscal Year 2021 Revenue Guidance
TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...